MKI67 and breast cancer: High tumor proliferation rate has been associated with aggressive tumor behavior in many malignancies, and MKI67 IHC is used in the clinical setting in breast cancer prognostic classification (35) and gastroenteropancreatic neuroendocrine tumor classification (36), among others.